Equities

Zepp Health Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Zepp Health Corp

Actions
  • Price (MXN)70.00
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta1.5006
Data delayed at least 20 minutes, as of Oct 17 2024 12:30 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Zepp Health Corp, formerly Huami Corp, is a Netherlands-based company primarily engaged in the consumer electronics and digital health technology industry. The Company focuses on developing smart wearable devices and digital health management platforms. Their key product is the Zepp Digital Health Management Platform, which is a cloud-based system integrating smart devices, biometric sensors, Artificial Intelligence (AI) chips, and data algorithms. It aims to provide users with 24/7 actionable insights to support health, fitness, and wellness management. The platform powers a range of products including smartwatches, fitness bands, smart rings, and hearables under the Amazfit and Zepp brand names. Additionally, the Company offers AI-driven services such as Zepp Aura for sound-based wellness and Zepp Clarity for hearing health. The Company has two reportable segments the Xiaomi wearable products segment and Self-branded products and others segment.

  • Revenue in USD (TTM)233.27m
  • Net income in USD-66.00m
  • Incorporated2014
  • Employees765.00
  • Location
    Zepp Health CorpEdisonweg 44 B08GORINCHEM 4207 HGNetherlandsNLD
  • Phone+31 616086658
  • Websitehttps://www.huami.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ZEPP:NYQ since
announced
Transaction
value
Wild Technologies Ai Ltd-Core Assets & Intellectual PropertyDeal completed31 Aug 202531 Aug 2025Deal completed-60.69%--
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.